Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues.
The effects of 2-chloro-2'-deoxyadenosine, beta-D-arabinofuranosyl-2-fluoroadenine, and 5-aza-2'-deoxycytidine on promoter methylation of the selected tumor suppressor genes (i.e., ERalpha, BRCA1, E-cadherin, PTEN, and APC) were estimated using methylation-sensitive restriction analysis (MSRA) in K562 cells (human erythroleukemic cell line) and MCF-7 cells (human breast cancer cell line). In both cell lines all tested drugs completely reduced methylation of PTEN and APC promoters. The results indicate that the tested nucleoside analogues, which are known inhibitors of DNA synthesis, also are implicated in indirect (or direct in the case of 5-aza-dCyd) regulation of post-replicative DNA modifications (i.e., DNA methylation).
Krawczyk
B
B
Department of Biomedicinal Chemistry, Medical University of Lodz, Lodz, Poland.
Fabianowska-Majewska
K
K
D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D015820:Cadherins / Q000235:genetics; D045744:Cell Line, Tumor; D017338:Cladribine / Q000494:pharmacology; D019175:DNA Methylation; D000077209:Decitabine; D047628:Estrogen Receptor alpha / Q000235:genetics; D017491:Genes, APC; D019398:Genes, BRCA1; D006801:Humans; D020014:K562 Cells; D009705:Nucleosides / Q000494:pharmacology*; D051059:PTEN Phosphohydrolase / Q000235:genetics; D011401:Promoter Regions, Genetic; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology
D015820:Cadherins; D047628:Estrogen Receptor alpha; D009705:Nucleosides; D017338:Cladribine; D000077209:Decitabine; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human; D014740:Vidarabine; D001374:Azacitidine; C024352:fludarabine